We just received data on a new analyst forecast for $MA. James Friedman from Susquehanna set a price target of 665.0 for MA.
To track analyst ratings and price targets for $MA, check out Quiver Quantitative's $MA forecast page.
Should you buy $MA?
Some analysts are better than others. To view the past performance of Susquehanna, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$MA Price Targets
Multiple analysts have issued price targets for $MA recently. We have seen 18 analysts offer price targets for $MA in the last 6 months, with a median target of $655.5.
Here are some recent targets:
- James Friedman from Susquehanna set a target price of $665.0 on 05/01/2026
- Matthew Coad from Truist Securities set a target price of $590.0 on 04/24/2026
- Andrew Bauch from BMO Capital set a target price of $605.0 on 04/22/2026
- Bryan Keane from Citigroup set a target price of $675.0 on 04/14/2026
- Adam Frisch from Evercore ISI Group set a target price of $550.0 on 04/01/2026
- Timothy Chiodo from UBS set a target price of $650.0 on 03/31/2026
- Dominick Gabriele from Loop Capital set a target price of $631.0 on 03/31/2026
$MA Insider Trading Activity
$MA insiders have traded $MA stock on the open market 23 times in the past 6 months. Of those trades, 0 have been purchases and 23 have been sales.
Here’s a breakdown of recent trading of $MA stock by insiders over the last 6 months:
- HAI LING (President, AP, Europe, MEA) has made 0 purchases and 23 sales selling 8,971 shares for an estimated $4,478,314.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
$MA Revenue
$MA had revenues of $8.4B in Q1 2026. This is an increase of 15.83% from the same period in the prior year.
You can track MA financials on Quiver Quantitative's MA stock page.
$MA Congressional Stock Trading
Members of Congress have traded $MA stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MA stock by members of Congress over the last 6 months:
- SENATOR SHELLEY MOORE CAPITO purchased up to $15,000 on 03/28.
- SENATOR SHELDON WHITEHOUSE sold up to $15,000 on 02/23.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 12/29.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 11/18.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
$MA Hedge Fund Activity
We have seen 1,523 institutional investors add shares of $MA stock to their portfolio, and 1,671 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- J. STERN & CO. LLP added 72,461,743 shares (+53535.0%) to their portfolio in Q4 2025, for an estimated $41,366,959,843
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 19,945,136 shares (-75.1%) from their portfolio in Q4 2025, for an estimated $11,386,279,239
- MASTERCARD FOUNDATION ASSET MANAGEMENT CORP removed 4,886,928 shares (-7.0%) from their portfolio in Q1 2026, for an estimated $2,407,691,687
- CARDANO RISK MANAGEMENT B.V. removed 3,669,548 shares (-90.1%) from their portfolio in Q1 2026, for an estimated $1,807,912,908
- BLACKROCK, INC. removed 1,857,641 shares (-2.6%) from their portfolio in Q4 2025, for an estimated $1,060,490,094
- FMR LLC removed 1,690,265 shares (-6.3%) from their portfolio in Q4 2025, for an estimated $964,938,483
- CAPITAL WORLD INVESTORS removed 1,476,057 shares (-30.6%) from their portfolio in Q4 2025, for an estimated $842,651,420
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
